CellCentric vs Compass Pathways

CellCentric vs Compass Pathways, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Compass Pathways on 57/100.

CellCentric logo
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Try CellCentric
Compass Pathways logo
Compass PathwaysAccelerating patient access to evidence-based innovation in mental health.
Try Compass Pathways

Where each one leads

CellCentric

  • our overall score: 60/100 against 57/100
  • funding raised: $375M against $294M

Compass Pathways

  • agent readiness: 48/100 against 32/100
  • domain rating: 65/100 against 35/100
  • headcount: 241 against 53
  • LinkedIn following: 39,951 against 28,695

At a glance

MeasureCellCentricCompass Pathways
What it isA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.Accelerating patient access to evidence-based innovation in mental health.
CategoryBiotechnology, Pharmaceuticals, Healthcare, BiotechBiotechnology, Healthcare, Mental Health, Pharmaceuticals
Sells toBusiness modelB2BB2B2C
OfferingServicesServices
Founded20032018
HeadquartersCambridge, United KingdomLondon, United Kingdom
StatusActiveActive

Size, funding and growth

MeasureCellCentricCompass Pathways
Employees53241
Total funding$375M$294M
Latest roundSeries DIPO
ValuationNot published$1.1B
LinkedIn followers28,69539,951

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellCentricCompass Pathways
StartupHub scoreOur 0-100 rating60/10057/100
Traction57/10060/100
Team60/10030/100
Search visibility44/10031/100
Quality68/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (32/100)D (48/100)
Domain ratingLink authority, 0-10035/10065/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellCentricCompass Pathways
HostingNot detectedAWS
CDNCloudflareCloudflare
CMSWordPressNot detected
FrameworksJqueryNext.js, Tailwind CSS
AnalyticsGoogle Analytics 4Google Tag Manager

CellCentric vs Compass Pathways: common questions

Which is better, CellCentric or Compass Pathways?

On our 0-100 score CellCentric rates higher (60/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do CellCentric and Compass Pathways compare on the numbers?

CellCentric leads on our overall score (60/100 against 57/100), funding raised ($375M against $294M). Compass Pathways leads on agent readiness (48/100 against 32/100), domain rating (65/100 against 35/100), headcount (241 against 53), LinkedIn following (39,951 against 28,695).

Read the full CellCentric review and pricing or the Compass Pathways review and pricing. You can also browse other CellCentric alternatives we track.